EUVIMEDEUVIMED entdecken
Crossref

To Study The Levels Of Ischemia Modified Albumin, Homocystine And Oxidised Ldl In Coronary Artery Disease Patients

Dr Nishant Dr Nishant, Dr Bibek Bhurer Yadav, Dr Shubham Goyal, Dr Sanjiv Kumar Bansal

IOSR Journal of Dental and Medical Sciences · 2026-02 · 25 (2) · 34-39

DOI: 10.9790/0853-2502033439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IOSR Journal of Dental and Medical Sciences, 2026-02. Verfasst von Dr Nishant Dr Nishant und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the levels of Ischemia-Modified Albumin (IMA), Homocysteine, and Oxidized Low-Density Lipoprotein (OxLDL) in patients with coronary artery disease (CAD) and assess their potential utility as diagnostic biomarkers.

Methods

A prospective case-control study was conducted at a tertiary care hospital, including 100 CAD patients and 100 age- and sex-matched healthy controls. Serum levels of IMA, Homocysteine, and OxLDLwere measured using ELISA-based assays. Statistical analysis included Student’s t-test, Receiver Operating Characteristic (ROC) curve analysis, and determination of sensitivity and specificity.

Results

Mean biomarker levels were significantly higher in CAD patients compared to controls (p < 0.001). ROC curve analysis demonstrated high area under the curve (AUC) values for all three biomarkers: IMA(0.98), Homocysteine (0.96), and OxLDL (0.99), indicating strong predictive accuracy. The optimal cutoffs for CAD diagnosis were 86.25 U/mL for IMA (94.5% sensitivity, 92.8% specificity), 12.9 µmol/L for Homocysteine (90.2% sensitivity, 89.3% specificity), and 121 U/L for OxLDL (96.8% sensitivity, 94.5% specificity). Notably, Homocysteine levels were significantly higher in males than females (p = 0.005), suggesting a potential sexbased variation in CAD risk.

Conclusion

Elevated levels of IMA, Homocysteine, and OxLDL are strongly associated with CAD, with OxLDL demonstrating the highest predictive value. These biomarkers may serve as valuable tools for early CAD detection and risk stratification, enabling timely clinical interventions. Further studies are warranted to validate their role in routine cardiovascular risk assessment.

Zitieren

APA

Nishant, D. N. D., Yadav, D. B. B., Goyal, D. S., & Bansal, D. S. K. (2026). To Study The Levels Of Ischemia Modified Albumin, Homocystine And Oxidised Ldl In Coronary Artery Disease Patients. IOSR Journal of Dental and Medical Sciences, 25(2), 34-39. https://doi.org/10.9790/0853-2502033439

Vancouver

Nishant DND, Yadav DBB, Goyal DS, Bansal DSK. To Study The Levels Of Ischemia Modified Albumin, Homocystine And Oxidised Ldl In Coronary Artery Disease Patients. IOSR Journal of Dental and Medical Sciences. 2026;25(2):34-39. doi:10.9790/0853-2502033439

BibTeX
@article{Nishant2026,
  author = {Nishant, Dr Nishant Dr and Yadav, Dr Bibek Bhurer and Goyal, Dr Shubham and Bansal, Dr Sanjiv Kumar},
  title = {To Study The Levels Of Ischemia Modified Albumin, Homocystine And Oxidised Ldl In Coronary Artery Disease Patients},
  journal = {IOSR Journal of Dental and Medical Sciences},
  year = {2026},
  volume = {25},
  number = {2},
  pages = {34--39},
  doi = {10.9790/0853-2502033439}
}
Kostenlos starten →